CANADA LIFE ASSURANCE Co

Insurance

Position in ADMA — Adma Biologics, Inc.

CIK 1046192 WINNIPEG, A2

Position in ADMA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,518,435

-$245,569 QoQ

Shares Held

181,414

-7.3% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 323 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. ADMA ranks #27 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	182,365	$90,586,166
2	REGN	Regeneron Pharmaceuticals, Inc.	86,761	$54,098,953
3	ALNY	Alnylam Pharmaceuticals, Inc.	69,102	$20,801,775
4	INCY	Incyte Corp	126,229	$14,309,319
5	ARGX	Argenx SE	14,868	$13,794,084
6	MRNA	Moderna, Inc.	152,228	$10,660,526
7	RPRX	Royalty Pharma plc	185,316	$10,390,668
8	EXEL	Exelixis, Inc.	155,922	$8,483,716

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,518,435	181,414	-7.3%	Shares	Sole	2026-08-13
2026-03-31	$1,764,004	195,783	-5.1%	Shares	Sole	2026-05-14
2025-12-31	$3,761,635	206,230	-18.1%	Shares	Sole	2026-02-13
2025-09-30	$3,693,176	251,922	-0.6%	Shares	Sole	2025-11-17
2025-06-30	$4,617,018	253,543	-2.3%	Shares	Sole	2025-08-15
2025-03-31	$5,147,726	259,462	-6.2%	Shares	Sole	2025-05-15
2024-12-31	$4,743,192	276,571	-1.4%	Shares	Sole	2025-02-13
2024-09-30	$5,607,354	280,508	+264.3%	Shares	Sole	2024-11-13
2024-06-30	$860,781	76,993	+42.5%	Shares	Sole	2024-08-12
2024-03-31	$356,723	54,049	+114.3%	Shares	Sole	2024-05-13
2023-12-31	$113,980	25,217	0.0%	Shares	Sole	2024-02-13
2023-09-30	$90,276	25,217	+215.5%	Shares	Sole	2023-11-14
2023-06-30	$29,490	7,992	0.0%	Shares	Sole	2023-08-10
2023-03-31	$26,453	7,992	0.0%	Shares	Sole	2023-05-12
2022-12-31	$31,008	7,992	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.